Association between oral microbial nitrate metabolism and poor prognosis in acute ischemic stroke patients with a history of hypertension

J Oral Microbiol. 2024 Jul 23;16(1):2382620. doi: 10.1080/20002297.2024.2382620. eCollection 2024.

Abstract

Background: Oral microbes mediate the production of nitric oxide (NO) through the denitrification pathway. This study aimed to investigate the association between oral microbial nitrate metabolism and prognosis in acute ischemic stroke (AIS) patients.

Methods: This prospective, observational, single-center cohort study included 124 AIS patients admitted within 24 hours of symptom onset, with 24-hour ambulatory blood pressure data. Oral swabs were collected within 24 hours. Hypertensive AIS patients were stratified by the coefficient of variation (CV) of 24-hour systolic blood pressure. Microbial composition was analyzed using LEfSe and PICRUSt2 for bacterial and functional pathway identification.

Results: Significant differences in oral microbiota composition were observed between hypertensive AIS patients with varying CVs. Lower CV groups showed enrichment of nitrate-reducing bacteria and "Denitrification, nitrate => nitrogen" pathways. The TAX score of oral nitrate-reducing bacteria, derived from LASSO modeling, independently correlated with 90-day modified Rankin Scale scores, serving as an independent risk factor for poor prognosis. Mediation analyses suggested indirect that the TAX score not only directly influences outcomes but also indirectly affects them by modulating 24-hour systolic blood pressure CV.

Conclusions: AIS patients with comorbid hypertension and higher systolic blood pressure CV exhibited reduced oral nitrate-reducing bacteria, potentially worsening outcomes.

Keywords: Oral microbiota; acute ischemic stroke; blood pressure; hypertension; nitric oxide; prognosis.

Grants and funding

J.Y. was supported by the National Natural Science Foundation of China [NSFC82171317] and the Guangdong Natural Science Foundation [2022A1515010477]. H.Z. was supported by the Guangzhou Key Research Program on Brain Science [202206060001].